These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis. Otto C; Hofmann J; Ruprecht K Med Hypotheses; 2016 Jun; 91():109-113. PubMed ID: 27142157 [TBL] [Abstract][Full Text] [Related]
3. The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review. Ruprecht K Expert Rev Clin Immunol; 2020 Dec; 16(12):1143-1157. PubMed ID: 33152255 [No Abstract] [Full Text] [Related]
4. The Interaction between Viral and Environmental Risk Factors in the Pathogenesis of Multiple Sclerosis. Tarlinton RE; Khaibullin T; Granatov E; Martynova E; Rizvanov A; Khaiboullina S Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30646507 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism. Serafini B; Rosicarelli B; Veroni C; Mazzola GA; Aloisi F J Virol; 2019 Dec; 93(24):. PubMed ID: 31578295 [TBL] [Abstract][Full Text] [Related]
8. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ascherio A; Munger KL Ann Neurol; 2007 Apr; 61(4):288-99. PubMed ID: 17444504 [TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies. Fernández-Menéndez S; Fernández-Morán M; Fernández-Vega I; Pérez-Álvarez A; Villafani-Echazú J J Neurol Sci; 2016 Feb; 361():213-9. PubMed ID: 26810546 [TBL] [Abstract][Full Text] [Related]
11. [Infection by Epstein-Barr virus and multiple sclerosis]. Alonso A; Egüés Olazábal N; Ayo Martín O Neurologia; 2006 Jun; 21(5):249-55. PubMed ID: 16788867 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr Virus (EBV) and Multiple Sclerosis Disease: A Biomedical Diagnosis. Alanazi A Comput Intell Neurosci; 2022; 2022():3762892. PubMed ID: 36082345 [TBL] [Abstract][Full Text] [Related]
13. Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. O'Gorman C; Lucas R; Taylor B Int J Mol Sci; 2012; 13(9):11718-11752. PubMed ID: 23109880 [TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis and environmental factors: the role of vitamin D, parasites, and Epstein-Barr virus infection. Correale J; Gaitán MI Acta Neurol Scand; 2015; 132(199):46-55. PubMed ID: 26046559 [TBL] [Abstract][Full Text] [Related]
15. Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis. Tschochner M; Leary S; Cooper D; Strautins K; Chopra A; Clark H; Choo L; Dunn D; James I; Carroll WM; Kermode AG; Nolan D PLoS One; 2016; 11(2):e0147567. PubMed ID: 26849221 [TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy. Aloisi F; Giovannoni G; Salvetti M Lancet Neurol; 2023 Apr; 22(4):338-349. PubMed ID: 36764322 [TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus and multiple sclerosis: Updating Pender's hypothesis. Laurence M; Benito-León J Mult Scler Relat Disord; 2017 Aug; 16():8-14. PubMed ID: 28755684 [TBL] [Abstract][Full Text] [Related]
18. Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update. Ascherio A; Munger KL Semin Neurol; 2016 Apr; 36(2):103-14. PubMed ID: 27116717 [TBL] [Abstract][Full Text] [Related]